Keith Geraghty

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:www.researchgate.net

Dr. Keith Geraghty, Ph.D., is a Honorary Research Fellow at the University of Manchester (UK) in the Centre for Primary Care. His main research interests are patient safety and harms, burnout in doctors and health professionals, medically unexplained illness and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).[1]

Geraghty serves on the editorial board of the journal, Fatigue: Biomedicine, Health & Behavior.[2] He is associate editor of the Journal of Health Psychology

Publications[edit | edit source]

2015[edit | edit source]

  • Nov 7, 2015, Deviant cellular and physiological responses to exercise in Myalgic Encephalomyelitis and chronic fatigue syndrome[3] - (Full text)

2016[edit | edit source]

  • May 1, 2016, Doing Research in Chronic Fatigue Syndrome with Chronic Fatigue. 12th International IACFS/ME Research and Clinical Conference[4] - (Full text)
  • Jun 27, 2016, The 'all in the mind' myth of myalgic encephalomyelitis/chronic fatigue syndrome[5] - (Full text)
  • Aug 1, 2016, Chronic fatigue syndrome: is the biopsychosocial model responsible for patient dissatisfaction and harm?[6] - (Full text)
  • Sep 15, 2016, Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent[7] - (Full text)
  • Sep 23, 2016, Editorial - 'PACE-Gate': When clinical trial evidence meets open data access[8] - (Full text)
  • Dec 5, 2016, Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome[9] - (Abstract)
  • 2016, Chronic Fatigue Syndrome and the Biopsychosocial Model: Accounting for Harm in the Medical Encounter Conference paper[10] - (Conference abstract)

2017[edit | edit source]

  • Jun 14, 2017, Editorial - Further Commentary on the PACE Trial: Biased Methods and Unreliable Outcomes[11] - (Full text)
  • Aug 29, 2017, Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys[12] - (Full text)

2018[edit | edit source]

  • 2018, Rethinking the treatment of chronic fatigue syndrome—A reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT[13](Full text)
  • 2018, Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter[14] - (Full text)
  • 2018, Are ME/CFS Patient Organizations "Militant"?[15](Abstract)

2019[edit | edit source]

  • 2019, The Importance of Accurate Diagnosis of ME/CFS in Children and Adolescents: A Commentary[16](Full text)
  • 2019, The 'Cognitive Behavioural Model' of Chronic Fatigue Syndrome: Critique of a Flawed Model[17](Abstract)
  • 2019, A logistic regression analysis of risk factors in ME/CFS pathogenesis[18] - (Full text)

2020[edit | edit source]

  • 2020, Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified[19] - (Full text)
  • 2020, The Negative Impact of the Psychiatric Model of Chronic Fatigue Syndrome on Doctors' Understanding and Management of the Illness[20] - (Full text)
  • 2020, Ethical Psychotherapeutic Management of Medically Unexplained Symptoms[21] - (Abstract, Book Chapter)

2021[edit | edit source]

  • 2021, The 'medically unexplained symptoms' syndrome concept and the cognitive-behavioural treatment model[22] - (Full text)

Talks, interviews and blogs[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. IACFS. "May 2016 Newsletter | Dr Keith Geraghty Doing CFS Research".
  2. "Fatigue: Biomedicine, Health & Behavior". tandfonline.com. Retrieved November 1, 2019.
  3. Twisk, Frank; Geraghty, Keith (November 11, 2015). "Deviant Cellular and Physiological Responses to Exercise in Myalgic Encephalomyelitis and Chronic Fatigue Syndrome" (PDF). Jacobs Journal of Physiology. 1 (2): 007.
  4. Geraghty, Keith (2016), Doing Research in Chronic Fatigue Syndrome with Chronic Fatigue at 12th International IACFS/ME Research and Clinical Conference, October 27-30, 2016, Fort Lauderdale, Florida, US
  5. Geraghty, Keith (June 27, 2016). "The 'all in the mind' myth of myalgic encephalomyelitis/chronic fatigue syndrome". Nursing in Practice.
  6. Geraghty, Keith; Esmail, Aneez (August 1, 2016). "Chronic fatigue syndrome: is the biopsychosocial model responsible for patient dissatisfaction and harm?". British Journal of General Practice. 66 (649): 437-438. doi:10.3399/bjgp16X686473.
  7. Blease, Charlotte; Geraghty, Keith (September 15, 2016). "Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent". Journal of Health Psychology. 23 (1): 127–138. doi:10.1177/1359105316667798.
  8. Geraghty, Keith (September 23, 2016). "'PACE-Gate': When clinical trial evidence meets open data access". Journal of Health Psychology. 22 (9): 1106-1112. PMID 27807258.
  9. Blease, Charlotte; Havi, Carel; Geraghty, Keith (December 5, 2016). "Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome". Journal of Medical Ethics. 43 (43): 549-557. doi:10.1136/medethics-2016-103691. PMID 27920164.
  10. Geraghty, Keith (2016). "Chronic Fatigue Syndrome and the Biopsychosocial Model: Accounting for Harm in the Medical Encounter". University of Manchester. Retrieved March 30, 2019.
  11. Geraghty, Keith (May 2017). "Further Commentary on the PACE Trial: Biased Methods and Unreliable Outcomes". Journal of Health Psychology. 22 (9): 1209-1216. doi:10.1177/1359105317714486.
  12. Geraghty, Keith; Hann, Mark; Kurtev, Stoyan (August 29, 2017). "Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys". Journal of Health Psychology. 24 (10): 1318-1333. doi:10.1177/1359105317726152.
  13. Wilshire, C; Kindlon, T; Courtney, R; Matthees, A; Tuller, D; Geraghty, K; Levin, B (2018). "Rethinking the treatment of chronic fatigue syndrome—A reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT". BMC psychology. 6 (1): 1–12. PMC 5863477. PMID 29562932.
  14. Geraghty, Keith J.; Blease, Charlotte (June 2018). "Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter". Disability and Rehabilitation. 41 (25): 3092–3102. doi:10.1080/09638288.2018.1481149.
  15. Blease, Charlotte; Geraghty, Keith (July 2018). "Are ME/CFS Patient Organizations "Militant"". Bioethical Inquiry. 15 (3): 393–401. doi:10.1007/s11673-018-9866-5.
  16. Adeniji, Charles; Geraghty, Keith James (2019). "The Importance of Accurate Diagnosis of ME/CFS in Children and Adolescents: A Commentary". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00435. ISSN 2296-2360.
  17. Geraghty, Keith; Jason, Leonard; Sunnquist, Madison; Blease, Charlotte; Tuller, David; Adeniji, Charles (January 1, 2019). "The 'Cognitive Behavioural Model' of Chronic Fatigue Syndrome: Critique of a Flawed Model". Journal of Health Psychology. 6 (1): 2055102919838907. PMID 31041108.
  18. Lacerda, Eliana M.; Geraghty, Keith; Kingdon, Caroline C.; Palla, Luigi; Nacul, Luis (December 2019). "A logistic regression analysis of risk factors in ME/CFS pathogenesis". BMC Neurology. 19 (1): 275. doi:10.1186/s12883-019-1468-2. ISSN 1471-2377. Unknown parameter |authorlinklink= ignored (help)
  19. Geraghty, Keith; Scott, Michael J. (December 2020). "Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified". BMC Psychology. 8 (1): 13. doi:10.1186/s40359-020-0380-2. ISSN 2050-7283. PMC 7001321.
  20. Geraghty, Keith (July 2, 2020). "The negative impact of the psychiatric model of chronic fatigue syndrome on doctors' understanding and management of the illness" (PDF). Fatigue: Biomedicine, Health & Behavior. 8 (3): 167–180. doi:10.1080/21641846.2020.1834295. ISSN 2164-1846.
  21. O'Leary, Diane; Geraghty, Keith (August 27, 2021). "Ethical Psychotherapeutic Management of Patients with Medically Unexplained Symptoms: The Risk of Misdiagnosis and Harm". Oxford Handbook of Psychotherapy Ethics. doi:10.1093/oxfordhb/9780198817338.013.72. Retrieved January 13, 2022.
  22. Scott, Michael J; Crawford, Joan S; Geraghty, Keith J; Marks, David F (September 23, 2021). "The 'medically unexplained symptoms' syndrome concept and the cognitive-behavioural treatment model". Journal of Health Psychology. 27 (1): 3–8. doi:10.1177/13591053211038042. ISSN 1359-1053.
  23. Blease, Charlotte; Geraghty, Keith (December 6, 2016). "Mind the Gap: Ethical Failures in the Treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". BMJ blog. Retrieved December 4, 2018.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

chronic fatigue (CF) - Persistent and abnormal fatigue is a symptom, not an illness. It may be caused by depression, multiple sclerosis, fibromyalgia, chronic fatigue syndrome or many other illnesses. The term "chronic fatigue" should never be confused with the disease chronic fatigue syndrome.

biopsychosocial model (BPS) - A school of thought, usually based in psychology, which claims illness and disease to be the result of the intermingling of biological, psychological and social causes. (Learn more: me-pedia.org)

cognitive behavioral therapy (CBT) - A type of psychotherapy geared toward modifying alleged unhealthy thinking, behaviors or illness beliefs. One of the treatment arms used in the controversial PACE trial.

PACE trial A controversial study which claimed that CBT and GET were effective in treating "CFS/ME", despite the fact that its own data did not support this conclusion. Its results and methodology were widely disputed by patients, scientists, and the peer-reviewed scientific literature.

biopsychosocial model (BPS) - A school of thought, usually based in psychology, which claims illness and disease to be the result of the intermingling of biological, psychological and social causes. (Learn more: me-pedia.org)

PACE trial A controversial study which claimed that CBT and GET were effective in treating "CFS/ME", despite the fact that its own data did not support this conclusion. Its results and methodology were widely disputed by patients, scientists, and the peer-reviewed scientific literature.

bias Bias in research is "a systematic deviation of an observation from the true clinical state". (Learn more: me-pedia.org)

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

cognitive behavioral therapy (CBT) - A type of psychotherapy geared toward modifying alleged unhealthy thinking, behaviors or illness beliefs. One of the treatment arms used in the controversial PACE trial.

medically unexplained physical symptoms (MUPS) - Technically, this term means that no cause or explanation for the patient's symptoms has yet been found. However, patients diagnosed with "MUPS" are generally lumped into a psychosomatic, or psychologically-caused category by those in the medical profession, without any scientific basis for doing so.

medically unexplained physical symptoms (MUPS) - Technically, this term means that no cause or explanation for the patient's symptoms has yet been found. However, patients diagnosed with "MUPS" are generally lumped into a psychosomatic, or psychologically-caused category by those in the medical profession, without any scientific basis for doing so.

BMJ The BMJ (previously the British Medical Journal) is a weekly peer-reviewed medical journal.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.